Safety of Transarterial Chemoembolization (TACE) in the Setting of an Elevated Bilirubin

Phase 1 Completed 5 enrolled University of Minnesota

NaSingle-groupOpen-labelTreatment

Summary

The aim of this study is to evaluate the safety of selective transarterial chemoembolization (TACE) of hepatocellular carcinoma (HCC) in the setting of an elevated total bilirubin, but relatively normal direct bilirubin.

Timeline

Start: 2018-01-02
Primary completion: 2021-12-31
Completion: 2022-02-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Background	Deoxyrubicin	Unknown	—	—

Safety of Transarterial Chemoembolization (TACE) in the Setting of an Elevated Bilirubin

Summary

Timeline

Drugs

Indications